Evan Zisholtz
Vice President, Corporate Development Immunai
Seminars
Thursday 10th September 2026
Which Platform Technologies are Widening the Immunology & Oncology Fields?
2:30 pm
- How much impact has AI/multi-modal data had on current approaches to drug discovery and translational drug development?
- How are we are validating new, and assessing novel versus de-risked targets?
- What type of clinical data would lead the field to reassess assumptions on a target?
